300 related articles for article (PubMed ID: 18272255)
21. Synthesis of 7-oxo-7H-naphtho[1,2,3-de]quinoline derivatives as potential anticancer agents active on multidrug resistant cell lines.
Dzieduszycka M; Bontemps-Gracz MM; Stefańska B; Martelli S; Piwkowska A; Arciemiuk M; Borowski E
Bioorg Med Chem; 2006 May; 14(9):2880-6. PubMed ID: 16458007
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological activity evaluation of 1H-benzimidazoles via mammalian DNA topoisomerase I and cytostaticity assays.
Coban G; Zencir S; Zupkó I; Réthy B; Gunes HS; Topcu Z
Eur J Med Chem; 2009 May; 44(5):2280-5. PubMed ID: 18692939
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of novel hybrid compounds of imidazole scaffold-based 2-benzylbenzofuran as potent anticancer agents.
Wang XQ; Liu LX; Li Y; Sun CJ; Chen W; Li L; Zhang HB; Yang XD
Eur J Med Chem; 2013 Apr; 62():111-21. PubMed ID: 23353748
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and preliminary evaluation of selected 2-aryl-5(6)-nitro- 1H-benzimidazole derivatives as potential anticancer agents.
Romero-Castro A; León-Rivera I; Avila-Rojas LC; Navarrete-Vázquez G; Nieto-Rodríguez A
Arch Pharm Res; 2011 Feb; 34(2):181-9. PubMed ID: 21380799
[TBL] [Abstract][Full Text] [Related]
25. Benzimidazole condensed ring systems. XII. Synthesis and anticancer evaluation of certain pyrido[1,2-a]benzimidazole derivatives.
el-Hawash SA; Badawey el-S A; Kappe T
Pharmazie; 1999 May; 54(5):341-6. PubMed ID: 10368827
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, physicochemical properties and antimicrobial activity of some new benzimidazole derivatives.
Ansari KF; Lal C
Eur J Med Chem; 2009 Oct; 44(10):4028-33. PubMed ID: 19482384
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, antimicrobial and cytotoxic activities of some 5-arylidene-4-thioxo-thiazolidine-2-ones.
Gouveia FL; de Oliveira RM; de Oliveira TB; da Silva IM; do Nascimento SC; de Sena KX; de Albuquerque JF
Eur J Med Chem; 2009 May; 44(5):2038-43. PubMed ID: 19027993
[TBL] [Abstract][Full Text] [Related]
28. Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases.
McBride CM; Renhowe PA; Heise C; Jansen JM; Lapointe G; Ma S; Piñeda R; Vora J; Wiesmann M; Shafer CM
Bioorg Med Chem Lett; 2006 Jul; 16(13):3595-9. PubMed ID: 16603352
[TBL] [Abstract][Full Text] [Related]
29. Novel benzimidazoles with potential antimicrobial and antineoplastic activities.
Rida SM; Soliman FS; Badawy ES
Pharmazie; 1986 Aug; 41(8):563-5. PubMed ID: 3786375
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of 5-substituted 2-methylbenzimidazoles with anticancer activity.
el-Naem ShI; el-Nzhawy AO; el-Diwani HI; Abdel Hamid AO
Arch Pharm (Weinheim); 2003 Mar; 336(1):7-17. PubMed ID: 12666249
[TBL] [Abstract][Full Text] [Related]
31. Microwave induced synthesis of novel 8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepines as potential antitumor agents.
Insuasty B; Orozco F; Quiroga J; Abonia R; Nogueras M; Cobo J
Eur J Med Chem; 2008 Sep; 43(9):1955-62. PubMed ID: 18222571
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, crystal structure and biological activities of copper(II) complexes with chelating bidentate 2-substituted benzimidazole ligands.
Saczewski F; Dziemidowicz-Borys E; Bednarski PJ; Grünert R; Gdaniec M; Tabin P
J Inorg Biochem; 2006 Aug; 100(8):1389-98. PubMed ID: 16740312
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and antitumor cytotoxicity of novel bis-benzimidazoles.
Singh AK; Lown JW
Anticancer Drug Des; 2000 Aug; 15(4):265-75. PubMed ID: 11200502
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of new 1,5-diazaanthraquinones with cytotoxic activity.
Manzanaro S; Vicent MJ; Martín MJ; Salvador-Tormo N; Pérez JM; del Mar Blanco M; Avendaño C; Menéndez JC; de la Fuente JA
Bioorg Med Chem; 2004 Dec; 12(24):6505-15. PubMed ID: 15556767
[TBL] [Abstract][Full Text] [Related]
35. One-pot double intramolecular homolytic aromatic substitution routes to dialicyclic ring fused imidazobenzimidazolequinones and preliminary analysis of anticancer activity.
Fagan V; Bonham S; Carty MP; Aldabbagh F
Org Biomol Chem; 2010 Jul; 8(14):3149-56. PubMed ID: 20485753
[TBL] [Abstract][Full Text] [Related]
36. 4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: potent and selective p70S6 kinase inhibitors.
Bandarage U; Hare B; Parsons J; Pham L; Marhefka C; Bemis G; Tang Q; Moody CS; Rodems S; Shah S; Adams C; Bravo J; Charonnet E; Savic V; Come JH; Green J
Bioorg Med Chem Lett; 2009 Sep; 19(17):5191-4. PubMed ID: 19632115
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
Paul K; Bindal S; Luxami V
Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues.
Congiu C; Cocco MT; Onnis V
Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978
[TBL] [Abstract][Full Text] [Related]
39. 2-Mercapto-N-(azolyl)benzenesulphonamides. IV. Syntheses of some 4-chloro-2-mercapto-5-methyl-N-(benzimidazol-2-yl)benzenesulph onamide derivatives with potential anticancer and anti-HIV activities.
Pomarnacka E; Brzozowski Z
Acta Pol Pharm; 1997; 54(3):215-21. PubMed ID: 9511447
[TBL] [Abstract][Full Text] [Related]
40. Efficient microwave-assisted synthesis and antitumor activity of novel 4,4'-methylenebis[2-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)phenols].
Insuasty B; García A; Quiroga J; Abonia R; Ortiz A; Nogueras M; Cobo J
Eur J Med Chem; 2011 Jun; 46(6):2436-40. PubMed ID: 21481989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
